Fatty acid mobilization and their use in adipose tissue;La mobilisation des acides gras et leur utilisation dans le tissu adipeux: Une nouvelle donne

Journal de la Societe de Biologie

Volumn 200, Issue 1, 2006, Pages 83-91

  Mazzucotelli, Anne ^a   Langin, Dominique ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845609186     PISSN: 12950661     EISSN: None     Source Type: Journal    
DOI: 10.1051/jbio:2006011     Document Type: Review

References (50)

1. Arch J. R. S. & Wilson S., Prospects for β3-adrenoceptor agonists in the treatment of obesity and diabetes. Int. J. Obesity, 1996, 20, 191-199.
2. Baar R. A. et al., Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-) mice. Am. J. Physiol. Endocrinol. Metab., 2005, 1, E187-E193.
3. Barbe P. et al., In situ assessment of the role of the β1-, β2- and β3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br. J. Pharmacol., 1996, 117, 907-913.
4. Bogacka I. et al., Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro. J. Clin. Endocrinol. Metab., 2005, 90, 6650-6656.
5. Bougneres P. et al., In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity. J. Clin. Invest., 1997, 11, 2568-2573.
6. Bursten S. L. et al., Interleukin-1 rapidly stimulates lysophosphatidate acyltransferase and phosphatidate phosphohydrolase activities in human mesangial cells. J. Biol. Chem., 1991, 31, 20732-20743.
7. Capeau J., Insulin signaling: mechanisms altered in insulin resistance. Med. Sci. (Paris), 2003, 8-9, 834-839.
8. Coleman R. A. & Lee D. P., Enzymes of triacylglycerol synthesis and their regulation. Prog. Lipid. Res., 2004, 2, 134-176.
9. Egan J. J. et al., Mechanism of hormone-stimulated lipolysis in adipocytes: translocation of hormone-sensitive lipase to the lipid storage droplet. Proc. Natl. Acad. Sci. USA, 1992, 18, 8537-8541.
10. Eubank D. W. et al., Peroxisome proliferator-activated receptor γ and chicken ovalbumin upstream promoter transcription factor II negatively regulate the phosphoenolpyruvate carboxykinase promoter via a common element. J. Biol. Chem., 2001, 32, 30561-30569.
11. Franckhauser S. et al., Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes, 2002, 3, 624-630.
12. Fredrikson G. et al., Hormone-sensitive lipase and monoacylglycerol lipase are both required for complete degradation of adipocyte triacylglycerol. Biochim. Biophys. Acta, 1986, 288-293.
13. Galitzky J. et al., The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J. Lipid. Res., 2001, 28, 536-544.
14. Guan H. P. et al., A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat. Med., 2002, 10, 1122-1128.
15. Haemmerle G. et al., Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J. Biol. Chem., 2002, 277, 4806-4815.
16. Hahn P. & Novak M., Development of brown and white adipose tissue. J. Lipid. Res., 1975, 2, 79-91.
17. Hellström L. et al., Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives. Diabetologia, 1996, 39, 921-928.
18. Jenkins C. M. et al., Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J. Biol. Chem., 2004, 47, 48968-48975.
19. Jensen M. D. et al., Influence of body fat distribution on free fatty acid metabolism in obesity. J. Clin. Invest., 1989, 4, 1168-1173.
20. Lafontan M. & Berlan M., Fat cell a2-adrenoceptors: the regulation of fat cell function and lipolysis. Endocrine Rev., 1995, 16, 716-738.
21. Lafontan M. et al., An unsuspected metabolic role for atrial natriuretic peptides. The control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in Humans. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 2032-2042.
22. Langin D. et al., Adipocyte lipases and defect of lipolysis in human obesity. Diabetes, 2005, 11, 3190-3197.
23. Langin D. et al., Millennium fat-cell lipolysis reveals unsuspected novel tracks. Horm. Metab. Res., 2000, 11-12, 443-452.
24. Large V. et al., Hormone-sensitive lipase expression and activity in relation to lipolysis in human fat cells. J. Lipid. Res., 1998, 25, 1688-1695.
25. Large V. et al., Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J. Lipid. Res., 1999, 26, 2059-2066.
26. Martinez-Botas J. et al., Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat. Genet., 2000, 4, 474-479.
27. Mauriège P. et al., Human fat cell β-adrenergic receptors: β agonist-dependent lipolytic responses and characterization of β-adrenergic binding sites on human fat cell membranes with highly selective beta1-antagonists. J. Lipid. Res., 1988, 15, 587-601.
28. Moro C. et al., Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. Faseb J., 2004, 7, 908-910.
29. Olswang Y. et al., A mutation in the peroxisome proliferator-activated receptor γ-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice. Proc. Natl. Acad. Sci. USA, 2002, 2, 625-630.
30. Osuga J. et al., Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc. Natl. Acad. Sci. USA, 2000, 97, 787-792.
31. Puigserver P. et al., A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell, 1998, 6, 829-839.
32. Reshef L. et al., Glyceroneogenesis and the Triglyceride/Fatty Acid Cycle. J. Biol. Chem., 2003, 278, 30413-30416.
33. Ricquier D. & Bouillaud F., Mitochondrial uncoupling proteins: from mitochondria to the regulation of energy balance. J. Physiol., 2000, 529, 3-10.
34. Ruan H. & Pownall H. J., Overexpression of 1-acyl-glycerol-3- phosphate acyltransferase-a enhances lipid storage in cellular models of adipose tissue and skeletal muscle. Diabetes, 2001, 2, 233-240.
35. Sengenès C. et al., Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J., 2000, 14, 1345-1351.
36. Sengenes C. et al., Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2002, 1, R257-R265.
37. Stich V. et al., Activation of a2-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects. Am. J. Physiol., 2000, 279, 499-504.
38. Stich V. et al., Activation of antilipolytic a2-adrenergic receptors by epinephrine during exercise in human adipose tissue. Am. J. Physiol, 1999, 277, R1076-R1083.
39. Tan G. D. et al., A "futile cycle" induced by thiazolidinediones in human adipose tissue? Nat Med, 2003, 7, 811-812; author reply 812.
40. Tansey J. T. et al., Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. PNAS, 2001, 98, 6494-6499.
41. Tavernier G. et al., Norepinephrine induces lipolysis in β1/β2/β3-adrenoceptor knockout mice. Mol. Pharmacol., 2005, 68, 793-799.
42. Tiraby C. & Langin D., Conversion from white to brown adipocytes: a strategy for the control of fat mass? Trends Endocrinol. Metab., 2003, 10, 439-441.
43. Tiraby C. & Langin D., PGC-1a, a transcriptional coactivator involved in metabolism. Med. Sci. (Paris), 2005, 1, 49-54.
44. Tiraby C. et al., Acquirement of brown fat cell features by human white adipocytes. J. Biol. Chem., 2003, 278, 33370-33376.
45. Tordjman J. et al., Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J. Biol. Chem., 2003, 21, 18785-18790.
46. Viguerie N. et al., Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia, 2005, 1, 123-131.
47. Villena J. A. et al., Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J. Biol. Chem., 2004, 45, 47066-47075.
48. Weyer C. et al., Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective β3-adrenoceptor agonist in humans. Diabetes, 1998, 47, 1555-1561.
49. Zimmermann R. et al., Decreased fatty acid esterification compensates for the reduced lipolytic activity in hormone-sensitive lipase-deficient white adipose tissue. J. Lipid. Res., 2003, 11, 2089-2099.
50. Zimmermann R. et al., Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science, 2004, 5700, 1383-1386.